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Multiple Antiviral Components from an Extract of
Dettura stramonium»
Committee Chairman: Dan C. DeBo
The objective of this project was to further characterize
the compound(s) from Datura stramonium leaves responsible
for antiviral activity. A variety of protein purification
techniques were explored in the isolation of the active
material.
The purification steps finally established as
useful were (in this order) : 60-80% eunmonium sulfate
precipitation, dialysis, heat^treatment at 6 0 *C, and
chromatography on DEAE-ce 1 lu lose followed by Sephadex G-200.
The first peak eluted (following the void volume peak) from
the G-200 column contained the majority of the antiviral
activity.
This peak was further characterized by SDS-PAGE,
tested for RNase activity, and digested with trypsin. All
antiviral fractions contained a protein of -17,000 MW and
the antiviral activity was destroyed by trypsin.
The
initial fractions from this peak also contained PKase
activity, while the remainder of the fractions were only
antiviral.
The heat-treated extract was also fractionated
using centrifugal filters having lOOK, 30K, and lOK
molecular weight cut-offs. These fractions were
characterized by SDS-PAGE, and tested for antiviral and
RNase activity.
The +10,000 (10,000-30,000 MW), +30,000
(30,000-100,000 MW), and +100,000 (above 100,000 MW)
molecular weight fractions were antiviral, while only the
+30,000 and +100,000 fractions showed RNase activity.
Data
suggest the antiviral material is present as a -87,000 MW
complex which is not precipitated by heat.
The data suggest
the antiviral complex is composed of proteins of -17,000 MW
and -12,000 MW, an antiviral protein of unknown size, and an
RNase-active protein.
Future studies of the material
present in the complex should help to elucidate the nature
of the components present.
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INTRODUCTION
The use of plants to treat disease has been a common
practice since the beginning of history.

Natural medicinaIs

have been used to treat diseases from cancer to warts with
varying degrees of success.

Some of these (such as quinine,

opium, and digitalis) have found their place in modern
medicine.

The CRC Handbook of Medicinal Herbs lists 365

plants of medicinal use world<^wide and the Medicinal Plants
Of the Mountain West contains references to 120 medicinal
plants found in our geographic area.

This number of plants

represents only a small fraction of the 265,000 different
species of plants which are available for study and testing.
It stands to reason that of these many plants a
percentage of them would have antiviral (viricidal or
virustatic) components.

Upon testing this turns out to be

the case (1,8,22,25).
The discovery of Pokeweed Antiviral Protein (PAP) in
1925 signalled the beginning of a new area of research,
plant antiviraI s .

Sap from pokeweed reduced the infectivity

of TMV when mixed together and inoculated onto a TMVsusceptible host.

This sap was further purified and a

protein was isolated which would inhibit TMV and a variety
of other viruses from plants and animals (8).

The discovery

of PAP led to research into other plants, and eventually
this led to the discovery of many other antiviral compounds
from plants.

Further testing would show that these

antivirals functioned by a number of different mechanisms.
Plant compounds function in a wide variety of ways to
achieve their antiviral effect.

Photosensitizers function

in concert with ultraviolet light to cause damage to viral
nucleic acids#

% i s damage is accomplished by one or more

of the following: DNA/protein cross-linking, guanine
oxidation, or singlet oxygen production (8).

Terpenoids

function as antivirals at the level of the membrane, either
by interference with the adsorption/penetration of the virus
or at the time of assembly and/or release (8).

Lignans

affect viruses at some early step of their infection, while
phenolic compounds appear to function at various key steps
during the virus life cycle (8) .

Proteins and peptides have

activities ranging from interference with early steps of the
virus infection to exerting their effects at the level of
protein synthesis <8).
Antiviral Proteins from Plants
Induced Antiviral Proteins
The induced antiviral proteins (lAVPs) are produced as
a result of a viral infection, and therefore are not always
present (3-7)•

These proteins can exert their effect at a

distance from the site of infection, and upon viral
challenge show marked inhibition.

Examples of these

proteins are antiviral factor (AVF) extracted from tobacco
mosaic virus infected leaves of Nlcotlana glutlnosa,'
inhibitor of virus replication <IVR) found in the culture
2

supernatant of TMV-infected tobacco protoplasts, and
antiviral substance (AVS) which is also found in the culture
medium of infected tobacco protoplasts (7,8,25).
Sela and Applebaum were the first to describe the
production of a substance in virus-infected plants which
when isolated would protect new plants from infection (26).
Sap from infected leaves was found to inhibit local lesion
production when mixed with virus and inoculated onto healthy
leaves.

The sap from uninfected leaves was found to be non-

inhibitory.

They postulated that the inhibitory substance

was being produced as a result of virus infection and
suggested that its activity might be similar to the action
of interferon observed in animal tissues (26).

Further work

showed that AVF was present in infected tissue, and could be
isolated using methods similar to those used for the
isolation of interferon from human leukocytes (25).

Further

work by Sela demonstrated that AVF was present in minute
G[uantities in uninfected tissues, and that virus infection
was directly responsible for the production of AVF in larger
quantities (25).
Gera et al. showed that infection of protoplasts from a
hypersensitive strain of tobacco with TMV caused the release
of an inhibitory substance into the protoplast culture
medium (5,25).

This substance, inhibitor of virus

replication (IVR), was found to inhibit virus replication in
protoplasts isolated from both hypersensitive and systemic

4
responding varieties of Sainsun tobacco*

IVR was found to be

inhibitory when applied up to 18 hours after infection with
TMV (5,7)*
Mitra isolated two antiviral substances (AVS) from the
tissue culture medium of TMV infected protoplasts (AVS-30
and AVS-65)

(25) •

AVS-30 was found in the medium of both

infected and uninfected protoplasts and was believed to be
present as an endogenous inhibitor, whereas AVS-65 was
produced as a response to TMV infection.

AVS-65 was able to

transfer resistance to TMV infection to protoplasts in a
manner reminiscent of interferon action (25)•

Endogenous Antiviral Proteins
Endogenous antiviral proteins (EAVPs), in contrast, are
always present within the plant*

These proteins did not

appear to exert their antiviral activity within the source
plant from which they were extracted, because no obvious
protection was observed.

However, these proteins were

antiviral in other plant species upon external or mechanical
inoculation (8-11) under laboratory conditions, and were
termed 'altruistic'*

Further research with Pokeweed

antiviral protein (PAP) has shown that this 'altruistic'
effect may not be the case (25)*
The EAVPs can be classified into three general
categories based upon their mode of action: proteins that
inhibit or inactivate eukaryotic ribosomes, proteins that
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induce an antiviral response, and proteins that prevent the
establishment of a viral infection by some mechanism other
than those just described.
Pokeweed antiviral protein (Phytolacca, amerlcana) ,
Gelonin (Gelonlum mjltiflorum), and Dianthin (Dianthus
caxyophyllus)are included in the category of ribosomal
inhibitory proteins (HIPs).

RIPs are capable of

inactivating the large 60S subunit of eukaryotic ribosomes
and the antiviral effect(s) may be dependent upon this
inactivation (8,9,13,14)•

The mechanism of inhibition

exhibited by PAP has been shown to be catalytic in nature,
implying that virus replication may be prevented as a result
of interference with the host ribosomes ability to bind
elongation factors (14)•

The inhibitor, entering the cell

during mechanical inoculation along with infective viral
RNA, inactivates the 60S subunit of the ribosome and
consequently stops viral multiplication.
aborted viral infection (14).

This results in an

When PAP was tested against

herpes simplex and poliovirus In vitro, it was found that
the activity was dependent upon the interaction of the virus
with the cellular membrane.

This interaction facilitated

the entry of PAP into the cell with subsequent inactivation
of the host cell ribosomes and cessation of protein
synthesis (8,15).
The mechaniem by which ribosomee are inactivated ih
vivo is thought to be due to the N-glycosidase activity of

6

RIPs.

This activity breaks the W-glycosidic bond at

adenine*^^ in the 28S rRNA which allows cleavage of the RNA
by aniline in vitro.

This cleavage is responsible for the

inability of ribosomes to bind elongation factors (EFl and
EF2) and the resultant inhibition of protein synthesis (14)•
The second mode of action is by the induction of a
systemic antiviral response (systemic resistance)•

The

treatment of one portion of the plant results in either the
entire plant mounting an antiviral response (Boerhmavia
diffusa)(16,17), or a response which is restricted locally
to the treated leaf (Chenopodium ambrosoides) (18) .

The

action of the inhibitor may be attributed to the blockage of
the host cell receptor or to interference with virus
synthesis within the host cell.

The actual mechanism by

which the inhibition occurs has not been elucidated.
Proteins which prevent the establishment of a viral
infection fall into the last category.

The antiviral effect

is of a localized nature, causing the inhibition of virus in
treated areas only.

Extracts of Datura have been shown to

cause this type of resistance (11) as well as extracts from
other solanaceous plants (21) and various plant lectins (8).
It was previously thought that Datura stramonium
extract inhibited the establishment of virus in a localized
reaction by competing for available receptors (10,11,19,20).
However, other studies found no evidence of virus-specific
receptors on the plasma membrane surface (31).

This
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evidence suggests that interference with the virus may occur
at a different stage in the infection.
It is possible that this interference is due to
degradation of the infective nucleic acids.

Research by

Saxena and colleagues shows that ricin (antiviral protein
from Riclnas communis) will abolish protein synthesis in
Xenopus oocytes when either injected or added to the oocyte
incubation medium.

The RNA glycosylase activity of ricin

removes a single base adjacent to the alpha sarcin site from
the 28 S RNA in Xsnopus oocytes (28) •

Therefore, it is

possible that the antiviral activity observed with other
plant antiviral proteins could be a result of RNase*like
activity.
Datura stramonium has been used for centuries
throughout the world for the treatment of cancers, tumors
and indurations.

In China it is used as a treatment for

flatulence, hyperacidity, and tuberculosis sweats; in Mexico
for birthing pains; in Costa Rica for tumors and ulcers; and
in Africa (by the Arabs) for the treatment of influenza and
asthma (1).

In the United States, this plant (leaves) was

used for the treatment of asthma, as an analgesic and anti
inflammatory, and also as a hallucinogen in Native American
religious ceremonies (2) •

The widespread use of this plant

as a medicinal suggests that this plant may contain
compounds which could be used therapeutically, some of which
may prove to be antiviral.
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Previous studies have shown that extracts of Datura
contain an endogenous inhibitor that when mixed with virus
and inoculated onto a permissive host exerts an antiviral
effect (9,10,11).

Apablaza and Bernier showed that an

extract from Datura leaves was inhibitory against TMV when
tested in a pinto bean local lesion assay.

This activity

was heat-labile (100*C for 10 minutes) and was retained by a
50,000 MW cutoff filter (10).

Grasso and Shepherd found

that upon purification by ion-exchange chromatography, an
inhibitor from Datura gave an intense double band of 17,000
MW when visualized by SDS-PAGE (9).

Using a partially

purified extract of Datura, Zipf determined that the
inhibitory activity was pH stable (pH 3-10) and was not
reduced upon treatment with papain, acid phosphatase, formic
acid, cysteine, or performic acid.

The inhibitory activity

was not affected by heating at 65*C-70’C for 10 minutes.
Antiviral activity was reduced upon treatment with trypsin
(10%), acetic anhydride (50%), and phenyl isocyanate (70%)

(1 1 ).
Purpose of study
The purpose of this study was to further characterize
the antiviral compound(s) from Datura stramonium leaves.
The purification was accomplished by

ammonium sulfate

precipitation of leaf homogenate and chromatography on a
DEAE-Cellulose column followed by a
This material was characterized by

Sephadex G-200 column.
agarose and acrylamide
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gel electrophoresis, and molecular weight fractionation.
The antiviral activity was evaluated with a Pinto
bean/Tobacco Mosaic Virus inhibition assay.

MATERIALS anS METHODS

Buffers:

The buffer used throughout these experiments was a

0.067H sodium phosphate dibasic/potassium phosphate
monobasic buffer at pH 6.0, pH 7.0, or pH 7.9.

Buffer

species were made as lOX solutions and stored at room
temperature (16-22"C).

For use, buffer species were diluted

10-fold with H O and mixed together until the desired pH was
2

reached.

Growth of plants: The pinto bean plants (Phaseolus vulgaris
var. Pinto) were grown in Peat Lite mix (Grace Sierra, Ca.)
in a ten^perature-^controlled growth room in a greenhouse.
Two seeds were planted per 4” plastic pot and watered when
the soil became dry (approximately every 2 days).

Datura

seeds were planted in plastic flats (24"xl2"x2") and grown
to the 2-leaf stage after which they were transplanted to
individual pots.

All plants were grown in a 16 hr light/8

hr dark photoperiod at 21*C to 2 7 "C (70*F to 80*F) .

Pinto

beans were used at 9-11 days (primary leaf stage), and the
Datura leaves were harvested at maturity and stored at -2 0 *C
until needed.

Protein content:

The protein content of samples was

determined by the use of the Micro EGA Protein Assay Reagent
Kit (Pierce, Rockford, II.) by either the tube or microplate
10
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method as described in the literature supplied with the kit.
Readings were taken at
the microplate method.

for the tube method and at

for

Where specified, the Coomassie

Brilliant Blue Protein Assay Reagent Kit (Pierce, Rockford,
II.) was used to assay for protein content.

In all cases a

standard curve was generated by diluting BSA (2 mg/ml) to
known concentrations and assaying under the conditions
dictated by the assay method.

By comparing the absorbance

of each fraction with the standard curve, a protein
concentration for each unknown could be determined.

Purification and Titration of TMV: A stock solution of
Tobacco Mosaic Virus (TMV) was prepared as follows:

Frozen

(-20*0) tobacco leaves infected with TMV were homogenized
1:1 in pH 7.0 buffer. This material was centrifuged at 3,473
X g (3500 rpm) for 15 min at 4*0 in a Beckman TY JS-4.2
rotor.

The pooled supernatant was centrifuged through a 30%

sucrose cushion at 111,000 x g (25,000 rpm) for 7 hours at
4*0 in a Beckman SW-2Ô rotor.

Pellets were resuspended in 2

ml of HjO for each pellet and loaded on 10-40% sucrose
gradients.

These were centrifuged at 125,000 x g (26,000

rpm) for 4 hours at 4*0 in a SW-28 rotor.

The opaque band

was harvested from the gradient, diluted with HgO, and
centrifuged at 111,000 x g (25,000 rpm) for 3 hours at 4*0
in a SW-28 rotor.

The supernatant was discarded and the

virus pellets resuspended in 3 ml of H^O per pellet.

This
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TMV suspension was stored at -20'C in 0.5 ml aliquots until
needed•
The virus stock was titrated by making serial 5-fold
dilutions in buffer, mixing 1:1 with additional buffer, and
adding Celite abrasive (15 mg/ml).

The inoculation was

performed by placing 200 /til of the mixture onto the half
leaf and rubbing the half-leaf with a fingertip.

The

infected plants were grown for 7 days, the leaves harvested,
and the lesions counted with the aid of a dissecting scope.
A lesion is defined as a necrotic spot on the leaf
surface, red-brown to gray in color and circular with
irregular edges.

Lesions will in some cases be bounded by a

light green area. The average number of lesions obtained
throughout the year varied with the season.

Control lesion

numbers obtained in the spring and fall were usually higher
than at other times of the year.

This agrees with

observations made by Zipf (11).

Preparation of the Datura extract:

Frozen (-20*0)

leaves of

Datura stramonium were homogenized 1:1 in cold (4*0) pH 7.0
buffer in the presence of 0.1% 8-Mercaptoethano 1 with a
Waring blendor.

The resultant homogenate was placed in 250

ml centrifuge bottles, and centrifuged at 18,200 x g (8000
rpm> for 50 minutes at 4*0 in a GSA rotor.

The pellets were

discarded and the supernatants pooled before precipitation
with ammonium sulfate.
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Protein precipitation was accomplished by a 60% to 80%
ammonium sulfate ^cut^. This cut had been previously
determined to contain the maximal antiviral activity from
Datura. (11) •

The pooled supernatant was brought to 60% of

saturation by the addition of solid ammonium sulfate and the
solution stirred overnight at 4*C.

The fluid was placed

into 250 ml centrifuge bottles and centrifuged at 18,200 x g
(8000 rpm) for l hour at 4*C in a GSA rotor.

The pellets

were discarded and the supernatant brought to 80% of
saturation with solid ammonium sulfate and stirred overnight
at 4*C*

The solution was centrifuged as above, the

supernatant discarded, and the pellets resuspended in a
total of 2 ml of pH 7.0 buffer per 40 ml of starting liquid.
This material was dialyzed at 4*C for 17 hours against four
2 liter changes of pH 7.0 buffer, with buffer changes after
2, 4, and 12 hours (Spectra-por dialysis tubing 12-14,000 HW
cutoff, Fisher).

The dialyzed material was stored at -20

in 1.2 ml aliquots until needed.

Inhibition Assay:

Mine to eleven day-old Pinto bean

{PhaseoXils vulgaris var. '*Pinto**) plants were used as the
assay host.

The assay unit used throughout the experiments

was the half-leaf.

A half-leaf is defined as the leaf

surface extending laterally from the central vein of the
primary leaf to the margin.
Serial five-fold dilutions of TMV were made in buffer

14

to a dilution previously determined to give 100 to 200
lesions per half-leaf.

The control virus dilution contained

virus dilution 1:1 with buffer.

Experimental samples

contained virus dilution l:i with the sample to be tested.
Celite abrasive was then added to a concentration of 15 mg
per ml of mixture.

Using a micropipettor, 200 fil of the

well-mixed sample was placed onto the leaf surface and
rubbed onto the entire half-leaf surface with a fingertip.
The inoculated plants were grown in the green-house for 7
days, the leaves harvested, and the lesions counted with the
aid of a dissecting microscope.

Heat Treatment of Datura extract:

zipf determined that the

thermal inactivation point of the antiviral material from
Datura was between 65*0 and 70*0, but no protein data were
included (11).
Two aliquots of Datura were thawed, and centrifuged at
12,500

X

g (14-15,000 rpm) in the benchtop microcentrifuge

for 30 seconds.
tubes.

The supernatants were transferred to new

One tube was placed on ice and one tube heat-treated

as follows:

The tube was placed in the 60*0 water bath for

10 minutes and then cooled on ice for 5 minutes.

The

material was centrifuged for 4 minutes at 12,500 x g (1415,000 rpm) in a benchtop microcentrifuge at 4*0 and the
supernatant transferred to a new tube.

The two aliquots

were tested for antiviral activity by making serial 10-fold

15

dilutions and testing as outlined above for the inhibition
assay.

Molecular yiltretiom: One ml of heat-treated Datura extract
was loaded onto a lOOKda Centricon (Amicon) filter and
centrifuged at 920 x g <2750 rpm) in an SS-34 (Sorvall)
rotor at 4*c for 1 hour*

The retentate was saved and the

filtrate was loaded onto a aOkDa filter and centrifuged for
1

hour at 4715 X g (6250 rpm) at 4^0.

The retentate was

saved and the filtrate was loaded onto a lOKOa cutoff filter
and centrifuged for 2 hours at 4715 x g (6250 rpm) at 4*c.
All material was resuspended to starting volume
buffer to obtain four different samples: +
retained hy the lOOK filter), +

3 0

kOa (<

1 0 0

( 1

ml) with

kDa (material

1 0 0

K and >3OK),

+10kDa (<30K and >10K), and *lOkDa (O-lOK)*

All samples

were stored at 4 ’c until use.

column <^&romatography:
DEAE-Cellulose:

DEAE-cellulose (Whatman dE-52) column

matrix was prepared as follows:

One volume of DE-52 matrix

was added to 15 volumes of 0.5M hydrochloric acid in H O,
2

stirred^ and allowed to settle for 30 minutes.

Fine

particles were removed by decanting and the matrix was
repeatedly washed with

until the pH was above 4.0.

The

matrix was soaked in 15 volumes of 0.5H sodium hydroxide in
H^O for 30 minutes and repeatedly washed in H O until the pH
2
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was below 7.0.

The DEAE^cellulose was then suspended in pH

7.9 buffer overnight at 4*C.

The excess buffer was removed,

and the resultant slurry poured into the column (Pharmacia,
Upsala, Sweden) at 4*C.

The column was equilibrated with 3

column volumes of buffer.
40 ml.

Column dimensions:

CM^celZuJfOse :

The final column bed volume was
1.5 cm diameter by 28 cm length.

CM-cellulose (Whatman CM-52) column matrix

was prepared as follows:

One volume of CM-52 matrix was

added to 15 volumes of 0.5M sodium hydroxide in
stirred, and allowed to settle for 30 minutes.

Fine

particles were removed by decanting and the matrix was
repeatedly washed with HgO until the pH was below 8.0.

The

matrix was soaked in 15 volumes of 0.5M hydrochloric acid in
H^O for 30 minutes and repeatedly washed in H^O until the pH
was above 7.0.

The CM-cellulose was then suspended in pH

6.0 buffer containing 0.01% sodium azide and aged at 4*C for
1

week before pouring.

The excess buffer was removed, and

the resultant slurry poured into the column at 4*C.

The

column was equilibrated with 3 column volumes of buffer.
The final column bed volume was 69 ml.

Column dimensions:

1.6 cm diameter by 35 cm length.

SeoAadex G^200:

Two grams of Sephadex G-200 (Pharmacia)

were mixed with two column volumes of pH 7.9 buffer,
autoclaved for 15 minutes (121*C and 15 atm) , and allowed to
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cool to 4*C.

Excess buffer was removed, the slurry poured

into the column, and the column equilibrated with 3 column
volumes of buffer at 4*C.
60 ml*

Column <limensions:

The final column bed volume was
1.6 cm diameter by 35 cm length.

The column void volume was determined using 0.5 mg/ml Blue
Dextran (average MW of 2,000,000).

Column chromatography of extract:
DEAE-^cellulosB :

Six aliquots of Datura, extract were thawed

and centrifuged for 1 minute at 12,500 x g (14-15,000 rpm)
at 4*C in a benchtop microcentrifuge to sediment any
particulate material.

The supernatants were transferred to

new Eppendorf tubes and heated in a 60*0 water bath for 10
minutes.

The tubes were removed and cooled on ice for 5

minutes, and centrifuged at 12,500 x g (14-15,000 rpm) in
the benchtop microcentrifuge for 4 minutes to sediment any
heat^aggregated material.

The supernatants were pooled and

brought up to 18.5 ml with pH 7.9 buffer.

The material was

loaded onto the DEAE-cellulose column and allowed to run
into the bed.

The walls of the column were washed with 12

ml of pH 7.9 buffer, and the washes allowed to run into the
bed.

The head-space was filled with buffer, the buffer

reservoir attached, and the fraction collector set to
collect 120 drop fractions (5 ml/tube).

Buffer (pH 7.9) was

allowed to wash the column by gravity feed.
fractions were monitored at

Eluted

until the absorbance had
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returned to background.

The adsorbed material was eluted

with a linear 0-1.4M sodium chloride gradient.
were tested for antiviral activity.

Fractions

In further

purifications, tubes containing the unadsorbed material were
pooled and concentrated using a Centriprep-10 centrifugal
filter (10,000 MW cut-off, Amicon).

CM-ceilulose;

The concentrated wash-through peak (pH 7.9)

from the DEAE-cellulose column was buffer-exchanged to pH
6.0 by the use of a Centriprep-10 centrifugal filter.

This

was accomplished by multiple resuspensions of the
centrifugally concentrated material with buffer pH 6.0.
Final volume of buffer-exchanged material was 1.2 ml.

This

material was resuspended to the starting volume of 5.2 ml
with buffer pH 6.0, and a 0.5 ml aliquot was removed for
testing.

The remainder of the material was diluted to 25 ml

with buffer and loaded onto the CM-cellulose column.

The

head-space was filled, and the column washed with buffer pH
6.0 until the Ajgo had returned to background collecting 5 ml
fractions.

Adsorbed material was eluted with a linear 0-lM

sodium chloride gradient until the A @o had returned to
2

background.

All fractions were stored at 4*C for testing.

Spphadex G-200;

The concentrated wash-through peak obtained

from the DEAE-cellulose column was resuspended to

1

% of the

G^200 bed volume with pH 7.9 buffer (final volume 0.6 ml).
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This material was loaded onto the G*200 column, and allowed
to drain into the bed.

The walls of the column were washed

with 1 ml of pH 7.9 buffer, the head-space filled, and the
buffer reservoir attached.

The column was washed with 3

column volumes of buffer, and 120 drop fractions (5 ml) were
collected.

The Ajgo readings were used to generate a column

elution profile.

Aliquots of each fraction were stored at

4*C for testing, and the remainder was stored at - 2 0 *C until
needed.

Sodium Dodecyl Sulfate-Polyacrylamide Gel Blectropboresis
(SDB*PAGB) :

Electrophoresis was carried out by the method

of Laemmli (27) in 12.5% polyacrylamide gels with a 4%
polyacrylamide stacking gel under denaturing (SDS-PAGE)
conditions•
Material which had previously proved to be too dilute
to be visualized by SDS-PAGE was concentrated by TCA
precipitation (31)•

Briefly, one volume of sample was miked

with four volumes of 5% trichloroacetic acid and incubated
overnight at 4*C.

The precipitated material was centrifuged

out of solution in a benchtop microcentrifuge for 15 min at
12,500 X g (14-15,000 rpm) and resuspended in a small volume
(50 fil) of 2X Laemmli Sample Buffer for electrophoresis.

4X Tris-Giveine Electrophoresis Running Buffer:
of glycine and

6

28.8 grams

grams of Tris base were dissolved in 250 ml
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of HjO and diluted to a final volume of 500 ml with H O.

For

2

use, 5 ml of 10% SOS was added to 125 ml of the 4X buffer
and diluted to 500 ml (denaturing gel).

Buffer is pH 8.3

when diluted to a IX concentration.

4X Tris-HCl Buffer dH

8 . 8

fl.5M Tris^;

45.5 grams of Tris

base was dissolved in 100 ml of HjO, adjusted to pH

8 .

with

8

IN HCl, and diluted to a final volume of 250 ml with HgO.

4X Tris-HCl Buffer PH

6 . 8

f0.5M Tris) :

6.05 grams of Tris

base was dissolved in 50 ml of HjO, adjusted to pH

6 . 8

with

IN HCl, and diluted to a final volume of 100 ml with H^O.

2X Laemmlj^Samole Buffer:

1.52 grams of Tris base, 20 ml of

glycerol, 2 grams of Sodium Dodecyl Sulfate (SOS) , 2 ml of
B-Mercaptoethanol, and 1 mg of Bromphenol Blue were
dissolved in 40 ml of HjO, adjusted to pH
and diluted to a final volume of

1 0 0

6 . 8

with IN HCl,

ml with HgO.

30% Acrvlamide/0.8% Bisacrvlamide Solution:

30 grams of

acrylamide and 0.8 grams of N,N'-methylene-bisacrylamide
were dissolved in 40 ml of H^O and diluted to a final volume
of 100 ml with HjO.

stored in the dark at 4*C.

Preparation of an Electrophoresis Gel (SDS-PAGE) :

The glass

plates and 1.5 mm spacers were cleaned with 95% ethanol
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before assembly.

The assembled plates were placed in a bag

and clamped vertically to a plexiglas stand for pouring.
The analytical gel was prepared as follows:
1 0

ml of 4X Tris^HCX pH

8 . 8

13 ml of HjO,

buffer, and 16.8 ml of the

acrylamide solution were mixed and degassed with a vacuum
pump.

To this mixture, 400 Ml of 10% SDS, 100 Ml of 10%

ammonium persulfate, and 20 Ml of TEMED were added, mixed
well, and poured between the glass plates using a
syringe fitted with a 18 gauge needle.

ml

1 0

This mixture was

then overlaid with 2-3 ml of H^O to exclude air and allowed
to polymerize for 30 minutes.
as follows:
2 . 6

1 1

The stacking gel was prepared

ml of HjO, 5 ml of 4X Tris-HCl pH

6

. , and
8

ml of the acrylamide solution were mixed and degassed.

To this mixture, 200 Ml of 10% SDS, 60 Ml of 10% ammonium
persulfate, and 20 Ml of TEMED were added.

The water

overlay on the analytical gel was removed and the well-mixed
stacking gel solution was poured as above.

A comb was

inserted and the stacking gel allowed to polymerize for 30
minutes.

The gel sandwich was then removed from the bag,

clamped in the electrophoresis apparatus, and the upper and
lower buffer chambers filled with running buffer pH 8.3
containing SDS.

The comb was removed and the wells rinsed

with running buffer before the samples were loaded.

SDS-PAGE I

All samples were mixed 1:1 with

2

x Laemmli Sample

Buffer, boiled for 5 minutes, centrifuged at 12,500 x g (14-
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15,000 rpm) for 10 seconds, and loaded onto the gels.
gels were electrophoresed at

The

V until the marker dye was

1 2 0

through the stacking gel, and then turned up to 200 V and
electrophoresed until the marker dye was 0.5 cm from the
bottom of the gel.

The dye front was marked with india ink

before staining as desired.
Molecular weight markers used:

Phosphorylase B (*97,400

MW), Bovine Serum Albumin (*68,000 MW), Ovalubumin (*46,000
M W ) , Carbonic Anhydrase (*30,000 MW), and Cytochrome C
(*12,300 M W ) .

SÈâisiBS:
Coomstssie Brilliant Blue Stain for Proteins:

Coomassie

Brilliant Blue staining was accomplished by staining the gel
in Coomassie stain (50% methanol/0.05% Coomassie Brilliant
Blue R /10% glacial acetic acid/40% H O) for 1.5 to 2 hours.
2

The stain solution was removed and the gel destained (5%
methanol/7% glacial acetic acid/

8

8

% HjO) until the blue

bands were visible against a clear background (27).

Silver Stainincr for Proteins:

Silver staining of the gels

was accomplished by the method of Wray (28) •

Each gel was

fixed in 50% methanol for 30 min and then washed in 2
changes of dH

2 0

for 15 min each.

prepared as follows:

The silver stain was

2.3 ml of a 3.6% solution of sodium

hydroxide was mixed with 20.3 ml of H O and 1.4 ml of 14.8M
2
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ammonium hydroxide was added.
2

0

To this mixture, 4 ml of a

% silver nitrate solution was added dropwise with constant

stirring.

An additional 72 ml of H O was added to this

solution.

The gel was soaked in the stain solution for 15

2

minutes, the stain removed, and the gel washed with
changes of HjO for 5 min each.

3

The gels were developed by

soaking in developer solution prepared as follows:

2.5 ml

of 1% citric acid and 0.25 ml of 36-37% formaldehyde were
brought up to 500 ml with H O.
2

The gels were soaked in this

solution until the bands were of the desired intensity, and
the developer removed.

The developing was stopped by

replacing the developer with 50% methanol.

Protein bands

are visible as gray^brown to black bands in a clear to
yellow background.

Molecular weight determination:
Bv SDS-PAGEX

Fractions of interest and marker proteins were

subjected to SDS-PAGE to determine the denatured molecular
weight of the protein(s) present in the fractions (see
above) .

After staining with silver, the migration of the

marker proteins relative to the dye front was used to
generate a calibration curve for the gel.

The relative

migration of unknown bands was compared to the calibration
curve and the molecular weight calculated (29) .

Bv Sephadex G^200:

The Sephadex G-200 column was calibrated
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by the use of the MW-GF-200 kit (Sigma, St. Louis, MO.)
This was accomplished by elution of proteins of a known
molecular weight from the column.
werei

8

The marker proteins used

-Amylase (-200,000 MW), Alcohol Dehydrogenase

(-150,000 MW), Bovine Serum Albumin (-66,000 MW), Carbonic
Anhydrase (-29,000 MW), and Cytochrome C (-12,400 MW).

Blue

Dextran (-2,000,000 MW) was used to determine the void
volume of the column.

The elution volumes of these marker

proteins were used to generate a calibration curve for the
column.

The elution volumes of the extract column fractions

were compared to this curve and approximate native molecular
weights were calculated for each fraction.

RHase Activity in Agarose Gels:

The presence of RNase

activity was monitored by the following procedure : 25 ^1 of
the sample was mixed with 25 nl of whole TMV and 48 /il of
HgO, and incubated on ice for 30 minutes.

To each tube, 2

Ml of 10% SDS was added to disrupt the virus.

Twenty /il of

loading dye (50% Sucrose/0.5% SDS/ 0.25% Bromphenol
blue/H

2 0

) was added to each 100 /il reaction mix.

to 60 Ml of each sample was loaded onto a

1

% agarose gel ( %

agarose/ix TA£/1%SDS) and electrophoresed at 100
completion.

Forty /il
1

v

to

The gels were washed in H^O for 1 hour to

remove the SDS, stained with ethidium bromide (20 Ml of a
mg/ml ethidium bromide solution per
hour, and destained with H^O.

1 0 0

ml of H^O) for

1

The gel was viewed with the

1
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aid of a UV transilluminator.

RNase activity was indicated

by the degradation of the TMV RNA band to fragments of a
lesser size and a concomitant loss of fluorescence in the
degraded RNA as compared to the control.

SOX TAB stock: 24.2 grams of Tris base, 5.71 ml of glacial
acetic acid, and 10 ml of 0.5M EDTA pH 8.0 were added to 40
ml of H O and diluted to
2

Running Buffer:

1

0

0

ml with H^O.

10 ml of 50X TAE and 5 ml of 10% SDS were

diluted to 500 ml with H^O.

1% Agarose g e l :

0.5 grams of electrophoretic grade agarose

was added to 50 ml of HgO, and microwaved on high until the
agarose was dissolved (45-60 seconds).
and 0.5 ml of
poured.

1

0

One ml of 50X TAE

% SDS were added, swirled to mix, and

The gel was allowed to cool and solidify before

use.

Inhibition of RNase Activity:

Twenty-five fil of each column

fraction (4-11) were treated by the addition of 2 /xl of
either RNasin or 0.5M EDTA.

After 30 minutes on ice, the

virus was added and incubated for an additional 30 minutes.
Two jul of 10% SDS and 20 fil loading dye were added to each.
The samples were loaded onto a 1% agarose gel, and
electrophoresed as above.

If RNase was inhibited, the band
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corresponding to the virus RNA would not be degraded to
smaller fragments.

Protease Treatment of Column Fractions:

Two 600 /il aliquots

of each G-200 column fraction were thawed for use in this
assay.

Twenty mg of trypsin conjugated to acrylic beads

(Sigma, St. Louis, MO) was added to each tube of one set of
G-200 Column fractions, and the second set of tubes were not
treated.

Buffer pH 7.9 was also treated with enzyme to

serve as a enzyme control, or untreated to serve as a
temperature control.

All samples were mixed well and

incubated at 37*0 for 24 hours with shaking.

The tubes were

removed from the water bath, and centrifuged at 12,500 x g
(14-15,000 rpm) to pellet the beads or any heat-pfecipitated
material.

The supernatants were removed to new tubes and

tested for activity in the inhibitor assay.

If the

antiviral activity was sensitive to protease treatment, a
reduction in antiviral activity would be observed by an
increase in lesion number compared to untreated column
fraction controls.

RESULTS
Titration of TMV
Serial 5-fold dilutions of the purified virus were made
in buffer ranging from 1:5 to 1:78,125.

The dilutions of

1:125 to 1:78/125 were inoculated onto pinto bean half
leaves as previously described.

The dilution of 1:3125 gave

236.6 ± 53 lesions per half-leaf (Table l). For our assay
system, an average of
optimal.

1

0

0

-

2

0

0

lesions per half-leaf is

This dilution falls on the linear portion of the

titration curve and was used as the standard virus dilution
in subsec[uent experiments.

Heat treatment of Datura extract
Serial 10-fold dilutions of the heated and unheated
Datura extract were made to 10*^, and the dilutions of 10^ to
10"^ were tested for activity by the inhibition assay.

This

experiment was performed in duplicate on two separate days.
These data showed that the heated extract was slightly more
inhibitory than the unheated material in both experiments.
The average IC
average of

1 0

50

was 10"^^ for the unheated material with an

*^“ for the heated material.

However, the

specific activity of the heated material was 3.5-fold higher
than the specific activity of the unheated material (Table
2 ).
The heat treatment of our extract at 6 0 *C is a valid
addition to our purification scheme for two reasons: .
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Table 1:

Titration of Tobacco Mosaic Virus (TMV)

TMV purified from infected tobacco leaves by density
gradient centrifugation was diluted in buffer pH 7.0 in a
serial 5-^foXd dilution scheme ranging from 1:5 to 1:78,125.
Each dilution was mixed 1:1 with buffer pH 7.0, abrasive
added, and inoculated at 200 fil per half-leaf.

The

inoculated plants were grown for an additional 7 days, the
leaves harvested, and the lesions counted with the aid of a
dissecting microscope.

The dilution of 1:3125 was the

dilution found to give a countable number of lesions per
half-leaf and was used as the standard virus dilution in
subsequent experiments.
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1
1

Dilution of Virus

{[

Mean*

I1

95% CL*

1:125

TNTC*

1:625

541.3

426 to 656

*1:3125

236.6

183 to 290

1:15625
1-------- 1£78125------

49.9
8.9

—

38 to 61
5 to 13

Table 1: Titration of TMV
'The number shown is an average of the lesion counts
obtained from
half-leaves.
8

^95% confidence limits for each sample were calculated from
the individual lesion counts for each half-leaf.
*Too Numerous To Count

1

1
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Table 2:

Heat Treatment of Datura Extract

Datura extract was heated to 6

0

for 10 minutes, cooled on

ice for 5 minutes, and centrifuged at 12,500 x g (14-15,000
rpm) to remove any heat-aggregated material.

The samples

were tested for antiviral activity by mixing serial
dilutions

( 1 0

*to

1 0

1

0

-fold

^) of the heated and unheated material

with the standard virus dilution and inoculating onto pinto
bean half-leaves as previously described.

In both of these

replicates there is a 3.5-fold increase in the specific
activity with heat treatment with a -56% recovery of
protein.
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1

Sample*
Expm I

1

xc«-

1

D

6

HD

6

Expm II D

6

______ HD

6

o/ml*

1

mg/ml of
protein^

1
1

Specific
activity^
■
759.SU/mg

I^q .2.45

281.8

0.37

10*2-75

562.3

0

501.2

0.37

1350.6U/mg

0

4800.0U/mg

10-2-7

1

0

^

1

0 0 0 . 0

.

.

2

2

2G99.2U/mg

1

1

Table 2: Heat Treatment of Datura Extract
^ICso unit is defined as the dilution of the extract which
inhibits 50% of lesion formation as compared to control.
^V/ml is the IC

50

units contained per ml of extract.

% g / m l of protein was determined by Coomassie Brilliant Blue
Protein assay.
^Specific activity is calculated by dividing the U/ml by
mg/ml to determine the IC units present per mg of total
protein.
50

^Abbreviations:

D : Unheated Datura, Preparation
HD : Heated Datura, Preparation
6

6

# 6

# 6
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1) About 50% of the protein present was precipitated, and 2)
The specific activity of the material increased
considerably.

The increase in specific activity may be due

to heat-inactivation or precipitation of interfering
compounds, or dissociation of these interfering substances
from the active material.

This final option may suggest a

method in which the material is kept in its inactive form in
vivo until conditions are met which result in the unmasking
of the active material.

Molecular Filtration
Several filters with different nominal molecular weight
cutoffs (lOOK, 3OK, and lOK) were used to fractionate the
heat-treated extract.

This was done to determine the size

(range of MW) of the active material in its native form.
The highest antiviral activity was observed in the +3 OK and
+100K fractions (Table 3).
Âpablaza and Bernier used molecular filters to
separate components in an extract of Datura (10).

They

found that the antiviral activity was confined to the high
molecular weight (+50,000 MW) fraction only.

The data

obtained in this study indicate that the activity was
present in the +100,000, +30,000, and +10,000 molecular
weight fractions.

These results are consistent with Zipf's

statement that there may be more than one inhibitory protein
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Table 3 :

Antiviral Activity of Molecular Filtration

Fractions
The fractionation of heated Datura extract through molecular
weight cut-off filters generated four fractions.

These

fractions were tested for antiviral activity in the
inhibition assay as previously described.

The +100K

fraction contains material which was retained by the lOOKda
cut-off filter, the +30K fraction contains material retained
by the 30Kda filter but not the lOOKda filter, the +10K
fraction contains the material retained by the lOKda filter
but not the 30Kda filter, and the -lOK fraction contains the
material which passed through the lOKda filter.
+3OK, and +

1 0

The +100K,

K fractions are all antiviral, while the -lOK

fraction is not.
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Sample

1

95% CL^

% Inhibition

237.3

155 to 319

NA*

+100K

4.0

1 to 7

98.3%

+3 OK

0 . 0

Control

|I

Mean*

|

0

1

0

0

. %
0

+10K

125.7

51 to 201

47.0%

-lOK

254.0

204 to 304

-7.0%

Table 3: Antiviral Activity of Molecular Filtration
Fractions
^The number shown is an average lesion count of 4 half**
leaves for experimental samples and
half-leaves for the
control.
8

^95% confidence limits for each sample were calculated from
the individual lesion counts for each half-leaf.
*Not applicable

1
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present in an extract from Datura (11).

The presence of

more than one active fraction has been observed for the
extracts of geranium (Pelargonium hortorum B.) and pepper
(Capsicum f m t e s c e n s L. ) where both high and low molecular
weight components are active (

1

0

).

SDS-PAGE Of Molecular Filtration Fractions
SDS-PAGE of these fractions show that the +100K, +3OK,
and -lOK fractions have many proteins in common.

The +10K

fraction shows no protein bands

in our

difference observed between the

+100K, +3OK, and -lOK

fractions is the absence of the

17,000 MW in the -lOK

fraction (Figure 1) .

gel. The only major

This -lOK fraction also has no

inhibitory activity.
The absence of protein bands in our +

1 0

K fraction and

presence of protein (evaluated by BCA protein assay),
suggest that either the protein is not staining or that the
active protein is of a molecular weight less that 12.5K
(smallest marker present on the gel)•

The latter is the

most probable explanation since other proteinaceous
antivirals have been shown to be of a low molecular weight,
i.e. meliacin (5000 to 6000 MW from Melia azedarach) and
several di- and tri-peptide carbobenzoxy derivatives of
phenylalanine ( )•
8
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Figure 1:

SD8-PA6E of Molecular Filtration Fractions

This is a 12.5% denaturing gel of the fractions obtained
from the molecular weight fractionation of heated Datura
extract.

1 0 0

m

1

of each fraction was mixed with

1 0 0

Ail of

2X Laemmli Sample Buffer, boiled for 5 minutes, and
electrophoresed as previously described.
stained to visualize the protein bands.

The gel was silver
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■^LVS,*- f'T

12.5K

Figure 1: SDS-PAGE of Molecular Filtration Fractions
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RMase Activity of Molecular Filtration Fractions
The samples obtained from the molecular filtration were
tested for RNase activity as previously described#

The

stained gel showed that of the four fractions, the +100K and
+3 OK had RNase activity while the +

1 0

K and the -lOK

fractions exhibited no RNase activity (Figure 2).

Column Chromatography:
DEAE-cellulose:

Fractionation through a DEAK-cellulose

column was accomplished by a modification of the method used
by Grasso and Shepherd (9) #

The material was loaded onto

the column which was then washed with buffer#

Adsorbed

material was eluted from the column with a linear 0-1.4M
NaCl gradient#

The absorbance at 280 nm of the fractions

collected from the column were monitored with a
spectrophotometer to generate a column elution profile
(Figure 3).

Fractions were pooled and tested for antiviral

activity in the inhibition assay#

Results showed that the

antiviral activity of the extract was confined to the
unadsorbed material and the gradient-eluted material was
largely non-inhibitory (Table 4)#

Due to these data, the

gradient elution step was omitted in subsequent DEAEcellulose chromatography of the extract, and only the
unadsorbed material was collected for further testing
(Figure 4)#
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Figure 2:

RNase Activity of MW Fractions

Twenty-five /il of molecular weight fractions (+100K, +3OK,
+10K, and -lOK), heated Datura extract (HD ) , and buffer pH
6

7.9

(TMV), were mixed with 25 /il of TMV and H^O to 100 /il.

These samples were incubated on ice for 30 minutes, and 2 /il
of 10% SDS was added to disrupt the virus.

20 /il of loading

dye was added to each sample and 40-60 /il of each was
electrophoresed on a 1% agarose gel at 10OV to completion.
The gel was washed with %0, stained with ethidium bromide,
and destained with H^O.

The bands were visualized with the

aid of a UV transilluminator.

The +100K, +3OK, and heated

Datura extract exhibit RNase activity, while the +10K and lOK fractions do not.
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Figure 2: RNase Activity of M W Fractions
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Figure 3 :

Elution Profile of DEAE-cellulose

Heat-treated Daturet extract was subjected to ion-exchange
chromatography on DEAE-cellulose resin.

The column was

washed with buffer pH 7.9 and then eluted with a linear 01.4M NaCl gradient to elute any adsorbed material.
Absorbance at 290 nm was used to generate the column
profile.

Two peaks were obtained, A and C.

A contains the

wash-through peak and C contains the gradient-eluted
material.

Each fraction is -5 ml.
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DCAE Elution Profile
0 to 1.4 M NaCl Gra<üent

0.3

^

0.2

^

0.1

JJ-LL

0.0
10

20
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40

50

60

70

F r a c tio n N u m b e r

Figure 3; Elution Profile of DEIAE^Cellulose
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Table 4:

Amtiviral Activity of OBAS-eallulose Column

Fractiona
Aliquots (0.1 ml) of each fraction in A-D were pooled and
tested for antiviral activity in the inhibition assay.
A encompassing fractions 1-24 was found to contain the
antiviral activity, while the rest of the pools had no
activity.

The material in pools B-D appear to exert a

stimulatory action on the virus which could indicate the
presence of some compound in the extract which could
function as a stimulator of virus activity.

Pool

44

1

Sample

|

Mean*

|1

95% CL'

11 % Inhibition

1

Control

46.6

37 to 56

NA*

[

A (1-24)

24.0

13 to 34

48 %

B (25-53)

129.1

99 to 159

-177.1%

C (54-71)

78.5

35 to 122

-68.5%

D (72-83)

61.5

46 to 70

-31.9%

Table 4: Antiviral Activity of DEAE-cellulose Column
Fractions
^The number shown is an average lesion count of
half
leaves for experimental samples and 16 half-leaves for the
control.
8

^95% confidence limits for each sample were calculated from
the individual lesion counts for each half-leaf.
*Not applicable
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Figure 4:

DBAE-celiulose Wash-through

In subsequent column purifications, the gradient elution was
not done, and only the wash-through was collected for
further testing.

This figure shows the elution profile of

the wash-through peak from the DEAE-cellulose column
generated from the A^gq values of the fractions.
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Fractionation through a DEAE-cellulose column allowed for
the removal of about 50% of the protein present in the heattreated extract, with one major peak of activity present in
the wash-through.

Since DEAE-cellulose is an anion

exchanger and binds positively-charged side groups or
proteins, the data led us to believe that the active
material has an overall negative or neutral charge.

CM^CBllulose;

A CM-celXulose column was used to fractionate

the concentrated, buffer^-exchanged material obtained from
the DEAE-cellulose column wash-through.

This material was

loaded onto the column, washed with buffer until the A^gg had
returned to background, and the adsorbed material eluted
with a linear 0-lM NaCl gradient.

The absorbance at 280 nm

of each fraction was used generate a column elution profile
for the CM-cellulose column (Figure 5) .

Seventy-six 5 ml

fractions were collected.
Aliquots (0.1 ml) of each fraction were pooled to
generate four distinct pools; A (fractions 1-30), B
(fractions 31-45), C (fractions 46-60), and, D (fractions
61-76).

These pools were tested for antiviral activity in

the inhibition assay, and pools B (31-45) and D (61-76)
contained the majority of the activity (Table 5)•

The data

suggest that the use of CM-cellulose (cation exchanger,
binds negatively charged material) to fractionate the
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Figure 5: Elution Profile of CM-cellulose Column
The wash-through peak from the DEAE-cellulose column was
concentrated and loaded onto a CM-cellulose ion-exchange
column.

The column was washed with buffer pH 6.0 and 5 ml

fractions were collected.

This elution profile was

generated from the Aggo values of the fractions.
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Table 5:

Antiviral Activity of CM-cellulose Fraction Pools

The 0.1 ml aliquots of the material obtained from the CMcellulose were pooled (Pools A-D) and tested for antiviral
activity in the inhibition assay.
antiviral in experiment I.

Pools & and D were

Pools B and D were desalted and

tested for antiviral activity in experiment II, where
neither was antiviral.

51

I

1

11 % Inhibition

Sample

Mean*

Control

209.0

177 to 241

NA*

A (1-30)

139.5

115 to 164

33.3%

B (31-45)

88.3

62 to 115

57.8%

C (46-60)

179.5

122 to 237

14.1%

D (61-76)

20.5

14 to 27

90.2%

103.1

92 to 114

NA

B (31-45)
No Salt

161.1

128 to 194

-56.3%

D (61-76)
No Salt

156.8

134 to 179

-52.1%

II Control

Table 5:

|1

95% Cl?

Antiviral Activity of CM-cellulose Fraction Pools

^The number shown is an average lesion count of
half
leaves for experimental samples and 16 half-leaves for the
control.
8

^95% confidence limits for each sample were calculated from
the individual lesion counts for each half-leaf.
r and II are two different experiments.
The values shown
are calculated with respect to the internal control of each
experiment.
♦Not applicable
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active material recovered from the DEAE-cellulose column
resulted in the active material binding to the column.
Pools B and D were desalted and buffer-exchanged

to

remove the NaCl present in solution from the gradient
elution.

The desalted pools were tested for antiviral

activity, and neither pool B or D were antiviral (Table 5) .
This loss of antiviral activity could be attributed to one
or all of the following:

1> Proteins may undergo

conformational changes in binding to ion-exchangers (32),
which could cause the adsorbed protein to be stripped of
cofactors necessary for its activity.

2) The salt

concentration of the fractions was sufficiently high to have
caused the precipitation or dénaturât ion of the virus
present.

3) The salt concentration of the fractions was

sufficiently high to have caused the precipitation or
dénaturation of the active material.

4) The salt

concentration of the fractions was sufficiently high to
interfere with the pinto beans (buffer containing 0.5M NaCl
mixed with the standard virus dilution and inoculated onto
pinto beans caused the leaves to die).

5) The active

material may be tightly bound to the column matrix and was
not eluted under the conditions used.

Seph^dex G-200:

Due to this loss of activity, fractionation

by a G-200 Sephadex column was substituted for the CMcellulose column.

G-200 Sephadex fractionates proteins on
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the basis of size, with little chance that necessary
cofactors would be stripped from the active material.
The unadsorbed material from the DEAE-cellulose column
was concentrated and loaded onto the Sephadex column.

The

column was washed with three column-volumes of buffer and
the absorbance of the collected fractions was used to
generate a column elution profile (Figure

6

)•

Aliquots of

the eluted fractions were pooled for testing in the
inhibition assay (pools A-F).

Antiviral activity was

present in pools A and B which corresponded to the void
volume (tubes 1-5) and the major peak (tubes 6-14) of the
column respectively (Table

6

).

Each of the individual

fractions encompassing pools A and B were then tested in the
inhibitor assay, and fractions 4-11 contained the majority
of the antiviral activity (Table 7 and Figure 7).

SD8-PA6E of Column Fractions
TCA-precipitated G-200 column fractions 4-11 were
electrophoresed on a 12.5% SDS-PAGE gel.

Upon silver

staining, all fractions were found to contain a band of
-17,000 MW with fractions 4 and 7-11 containing the majority
of this material.

Grasso and Shepherd also found a protein

of -17,000 which they believed was the active material
present in their extract from Datura (9) . Fractions 8-11
also contained a band of -12,000 MW (Figure

8

).

Using G-75 Sephadex for his separation, Zipf

54

Figure 6:

Sephadex G-200 Elution profile

The wash-torough peak from the DEAE-cellulose column was
concentrated and loaded onto a Sephadex G-200 size-exclusion
column.

The column was washed with buffer pH 7.9 and 5 ml

fractions were collected.
generated from the

This elution profile was

values of the fractions.
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Table 6;

Antiviral Activity of G-200 Sephadex Fractions

(Pooled)
The 0.1 ml alic[Uots of the material obtained from the G-200
Sephadex column were pooled (Pools A-F) and tested for
antiviral activity in the inhibition assay.

Pools A and B

were found to contain the antiviral activity, while pools CF showed stimulatory activity
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Mean'

95% CL*

% Inhibition

||

Control

80.3

58 to 102

»»•

i

A (1-5)

29.8

19 to 40

62.9%

1

1.9

1 to 3

97.6%

C (15-18)

126.3

107 to 145

-57.2%

D (19-24)

132.0

1 0 2

to 162

-64.4%

E (25-30)

147.1

113 to 181

-83.2%

F (31-36)

189.9

156 to 224

-136.5%

Sample

B (6-14)

|1

Table
: Antiviral Activity of G-200 Sephadex Fractions
{Pooled)
6

*The number shown is an average lesion count of
half
leaves for experimental samples and 16 half-leaves for the
control.
8

^95% confidence limits for each sample were calculated from
the individual lesion counts for each half-leaf.
*Not applicable
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Table 7:

Antiviral Activity of Individual G-200 Sephadex

Column Fractions
Each individual fraction encompassing pool A and B was
individually tested for antiviral activity in the inhibition
assay.

Fractions 1-14 were tested, and fractions 4-11 were

found to contain the majority of the antiviral activity
observed.
fraction

8

The peak of antiviral activity was observed at
, while the absorbance peak was in fraction

1

0

.
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Sample

]I

Control

Mean'

1

11 % Inhibition

95% CL*

78.0

53 to 103

NA

Fraction 1

213.4

141 to 285

-173.6%

Fraction 2

129.0

101 to 157

-65.4%

II

Fraction 3

137.3

64 to 211

-76.0%

1

Fraction 4

23.3

20 to 27

70.2%

Fraction 5

1

Fraction

7.75

6

1

.

0

to

1

85.9%

2 1

5 to 11

90.1%

Fraction 7

4.5

2

to

8

94.2%

Fraction

0 . 8

0

to

2

98.9%

1 . 0

0

to

2

98.7%

8

Fraction 9
Fraction 10

2*25

0 to 5

97.1%

Fraction 11

13.0

2 to 24

83.3%

Fraction

48.8

23 to 75

37.5%

Fraction 13

36.8

21 to 53

52.9%

Fraction 14

127.3

85 to 170

-63.1%

1 2

Table 7: Antiviral Activity of Individual G
Column Fractions

-

2 0 0

Sephadex

'The number shown is an average lesion count of 4 half
leaves for experimental samples and
ha If-leaves for the
control.
8

*95% confidence limits for each sample were calculated from
the individual lesion counts for each half-leaf.
*Not applicable
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Figure 7:

Antiviral Activity of Column Fractions 4-11

The inhibition data obtained by testing the individual G-200
fractions is shown super imposed on the elution profile of
the G-200 Sephadex column.

Fraction

8

contains the maximal

antiviral activity, while the absorbance peak is seen in
fraction

1 0

which is slightly less active.
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Figure 7: Antiviral Activity of Column Fractions 4 — 11

62

Figure

8

:

SDS-PAGE Of 6-200 Column Fractions

One-half ml of each G-200 column fraction was TCAprecipitated and resuspended in 60 Ml of 2X Laemmli Sample
Buffer for electrophoresis on a 12*5% SDS-PAGE gel.

The

resultant gel was silver stained to visualize the bands.
All samples contain a -17,000 MW band in common which is
faintly visible in fractions 5 and
all other fractions.

6

, and is easily seen in
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ia.5K

F igu re 8: SDS-PAGE of G -2 0 0 C olum n F r a c tio n s
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fractionated his extract and upon electrophoresis of this
material found no evidence of a 17,000 MW protein (11).
This may be due to the fact that Zipf^s gels were stained
with coomassie blue instead of silver.

Gels which I stained

with coomassie blue showed very little of this protein, but
by using the silver stain this protein was readily visible.
The large volwnes of eluate obtained by Zipf's G-75
fractionation of the extract may have diluted the material
present to a point too dilute to visualize without
concentration.

RMase activity in Agarose Gels
TMV was incubated with the G-200 column fractions 4-11
to determine whether the antiviral activity of the column
fractions was associated with RNase activity.

Upon gel

electrophoresis. Fractions 4-8 were found to degrade the TMV
RNA, with the major activity observed in fractions 4-7.
Fractions 9-11 had little or no RNase activity (Figure 9).

Inhibition of RNase Activity
The column fractions were treated with EDTA or RNasin
before mixing them with TMV to see if the RNase activity
could be inhibited.

After incubation, the samples were

electrophoresed on an agarose gel and stained with ethidium
bromide.

Treatment with RNasin (Figure 10) or EDTA (Figure

11) had no effect on RNase activity.
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Figure 9:

RNase Activity of Column Fractions

Twenty-five til of column fractions 4-11 (F4-F11), heated
Datura extract (HD6) , and buffer pH 7.9 ("MV) ^ were mixed
with 25 fil of TMV and H^O to 100

These samples were

incubated on ice for 30 minutes, and 2 /il of 10% SDS was
added to disrupt the virus.

Twenty til of loading dye was

added to each sample and 40-60 til of each was
electrophoresed on a 1% agarose gel at lOOV to completion.
The gel was washed with H O, stained with ethidium bromide,
2

and destained with H O.
2

The bands were visualized with the

aid of a UV transilluminator.

Fractions 4-7 and Datura

extract degraded TMV RNA, while fractions 9^11 showed little
or no RNase activity.
activity.

Fraction 8 exhibits some RNase
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F igu re 9: RNase A ctiv ity of Colum n F r a c tio n s
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Figure 10:

RNasin Treatment of Column Fractions

Twenty-five f&l of column fractions 4-11 (F4-F11) and heated
Datura extract (HD6) were treated with 2 Ml of RNasin and
incubated on ice for 30 minutes.

Twenty-five Ml of TMV and

Kfl to 100 Ml were added and incubated on ice for an
additional 30 minutes.
disrupt the virus.

Two Ml of 10% SDS was added to

Twenty m1 of loading dye was added to

each sample and 40-60 Ml of each was electrophoresed on a 1%
agarose gel at lOOV to completion.

The gel was washed with

HjO, stained with ethidium bromide, and destained with HjO.
The bands were visualized with the aid of a UV
transilluminator.

Treatment with the RNasin had little or

no effect on the RNase activity of the fractions.
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F igu re 10: R N asin T r e a tm e n t of C olum n F r a c tio n s
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Figure XI:

EDTA Treatment of Column Fractions

Twenty-five til of column fractions 4-11 (F4-F11) and heated
Datura extract (HD6> were treated with 2 /xi of 0.5M EDTA and
incubated on ice for 30 minutes.

Twenty-five /xl of TMV and

H O to 100 /xl were added and incubated on ice for an
2

additional 30 minutes.
disrupt the virus.

Two /xl of 10% SDS was added to

Twenty /xl of loading dye was added to

each sample and 40-60 /xl of each was electrophoresed on a 1%
agarose gel at lOOV to completion.

The gel was washed with

HjO, stained with ethidium bromide, and destained with HgO.
The bands were visualized with the aid of a UV
transilluminator.

Treatment with the EDTA had little or no

effect on the RNase activity of the fractions.
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The fact that RNase is not inhibited by the presence of EDTA
suggests that this RNase activity is not dependent on the
presence of divalent cations, a result which agrees with
results obtained by Zipf (11).

RNasin treatment of the

fractions also showed no inhibition of activity.

RNasin

functions by binding to the active site of some RNases and
blocking their activity (personal communication).

Protease Treatment of Column Fractions
The antiviral activity of the undigested G-^200
fractions was unaffected by incubating for 24 hours at 37
with the exception of fraction 7.

Treatment of the column

fractions with trypsin conjugated to acrylic beads destroyed
the antiviral activity of the fractions as compared to the
controls (Table 8).

Native Molecular Weight
Markers of known molecular weights were eluted from the
G-200 column and a calibration curve was generated by
plotting the Ve/Vo (elution volume of the marker/elution
volume of the blue dextran) of each marker against its'
molecular weight (Figure 12).

Comparison of the Ve/Vo for

column fractions 4-11 to the calibration curve gave a
molecular weight range for the proteins present in the
column fractions (Table 9).

Since the material eluted from

the column was present as one peak, an assumption could be
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Table 8:

Trypsin Treatment of Column Fractions

Two 600 111 aliquots of each fraction were thawed and one
aliquot of each was treated with 20 mg of trypsin conjugated
to acrylic beads.

Two 600 /xl aliquots of buffer were also

prepared, one aliquot treated with 20 mg of enzyme and the
other untreated.

All samples were incubated at 3 7 "C for 24

hours with shaking.
X g for

1

The samples were centrifuged at 12,500

minute to precipitate the beads or any heat-

aggregated material, and the supernatants collected for
testing in the inhibition assay as previously described.
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Sample

|1

Mean'

95% Cl/

Control

46.1

36 to 56

NA*

Buffer

61.3

9 to 113

NA*

Buffer+T

152.0

0 to 324

NA*

1

Fraction 7

133.0

74 to 192

-177.1%

1

Fraction 8

18.3

15 to 21

70.2%

\

Fraction 9

14.3

11 to 17

76.7%

II

Fraction 10

7.8

0 to 16

87.4%

Fraction 11

11.3

0 to 31

75.6%

Fraction 12

112.8

68 to 158

-84.1%

Fraction 7T

56.3

31 to 81

62.9%

Fraction 8T

136.0

51 to 221

10.5%

Fraction 9T

177.3

128 to 226

-16.6%

Fraction lOT

168.8

111 to 226

-11.0%

Fraction IIT

164.5

114 to 215

-8.2%

Fraction 12T

185.3

63 to 308

-21.9%

Table 8:

11 %Inhibition^

Trypsin Treatment of Column Fractions

'The value given is an average lesion count of 8 half-leaves
for the control and 4 half-leaves for each experimental.
^95% confidence limits for each sample were calculated from
the individual lesion counts for each half-leaf•95% CL^
^ h e % inhibition for the experimental samples have been
determined by comparison with internal controls. The
samples not treated with the enzyme are calculated with
respect to the buffer sample.
The enzyme-treated samples
are calculated with respect to the enzyme-treated buffer
sample.
Note: The T designation denotes treatment with trypsin for
24 hours at 37*0 with shaking.
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Figure 12:

G-200 Calibration Curve

Markers of a known molecular weight were loaded onto the G200 Sephadek column and eluted with buffer pH 7.9,
collecting 1 ml fractions.

The calibration curve was

generated by plotting the molecular weight of each marker
against its' Vg/V@ (marker elution volume/elution volume of
Blue Dextran) .

The molecular weight of each unknown

fraction was determined by calculating the V^/V© for each and
using this value to extrapolate the approximate molecular
weight from this curve.
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Table 9:

Calibration of the Sephadex

6

-

2

0

0

Column and

Determination of Native Molecular Weight
The known molecular weight and the elution volume of each
marker was used to generate Figure 12.

The V^/Vq calculated

for 6*200 fractions 4*11 were used to extrapolate to a range
of approximate molecular weights possible for the protein
complex present in each fraction.
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Sample
Blue Dextran

|

Ve*

II

Ve/Vo^

1r

Approx. MW^

19.44 ml
(VOID VOLUME)

1.00

B-Amylase

25.11 ml

1.29

200,000

Alcohol
Dehydrogenase

29.16 ml

1.50

150,000

BSA

30.78 ml

1.58

66,000

Carbonic
Anhydrase

44.55 ml

2.29

29,000

Cytochrome C

49.41 ml

2.54

12,400

Fraction 4
(VOID VOLUME)

20-25 ml

1.02-1.29

+320,000

Fraction S

25—30 ml

1.29-1.54

320,000180,000

Fraction 6

30—35 ml

1.54-1.80

180,000120,000

Fraction 7

35—40 ml

1.80-2.05

120,000-65,000

Fraction 8

40—45 ml

2.05-2.31

65,000-42,000

Fraction 9

45—50 ml

2.31-2.57

42,000-23,000

Fraction 10

50-55 ml

2.57-2.83

23,000-13,000

Fraction 11

55—60 ml

2.83-3.08

13,000-7,000

Table 9:

29

0

0

0

,

0

0

Calibration of the Sephadex G-200 Column and
Determination of Native Molecular Weight

'Values given are the elution volumes of each marker or
fraction.
^Values given are Ve divided by the Ve of Blue Dextran (Vo
for the column)
^All molecular weights given are approximate.
The MW of the
markers are given in the GF-3 bulletin supplied in the MWGF-200 kit from Sigma. The molecular weights of the column
fractions are extrapolated from the calibration curve.

0
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made that the material eluted is present as a complex.

This

would imply that the native molecular weight of the complex
is an average of the values obtained, or *87,000 MW.

DISCUSSION
At the start of this project, the main goal was to
isolate and purify to molecular homogeneity the antiviral
protein from our extract.

Upon obtaining a protein which

was homogenous, the second goal of the project was to
characterize this protein.

This project was based partly on

work done previously by Zipf (11).

Data obtained in the

study by Zipf suggested that there was probably only one
antiviral factor present in the extract of Datura.
antiviral factor was proteinaceous in nature, but

This
was

resistant to many treatments known to inactivate proteins«
The initial step in the purification of the antiviral
from a 60-80% ammonium sulfate precipitated fraction of the
extract was to subject this fraction to heat.

Previous work

(11) had shown that the activity of the extract was not
affected by temperatures up to 65*0 for 10 minutes.

Our

extract was heated to 60*0 for 10 minutes, and we found that
this heating did indeed remove about half of the protein
content from solution.

As a result, the specific activity

of our heat-treated extract was 3-4 times that of the
unheated material.
Fractionation of the heat-treated extract by the use of
centrifugal filters and subsequent testing in the inhibition
assay indicated that native molecular weight of the active
material was greater than 30,000.

These data suggest that

the active components may be present as a complex containing
79
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both low and high molecular weight components, or that there
is more than one antiviral factor present.

This has been

seen previously in other antiviral extracts (10)•
Electrophoresis under denaturing conditions shows that
these fractions are composed of proteins ranging from 10,000
to 100,000 mw which are present as either a complex or
aggregate large enough to be retained by these filters.

The

sample containing proteins between 30,000 and 10,000 shows
no visible bands but does possess antiviral activity.

This

indicates that there is either some compound which is not
visible under our electrophoresis/staining, or the material
is less than the resolution limit of our gel system (less
than 10,000 m w ) •

The latter is possible, as other compounds

such as small proteins, peptides, and enzymes have been
found to be antiviral (8).
An assay testing these samples for RNase activity
showed that the +100,000 MW and +30,000 MW samples had RNase
activity, while the samples less than 30,000 MW did not.
This indicates that the antiviral activity observed in the
greater than 30,000 MW fractions may be due in part to the
activity of an RNase.
Fractionation of the heat-treated extract through the
DEAE-cellulose and the Sephadex G-200 allowed us to further
purify our active material.

The one major peak obtained

from the G-200 column was antiviral.

Upon SDS-PAGE of the

individual fractions obtained from this column, all the
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antiviral fractions contained a protein with a molecular
weight of -17,000.

This agrees with previous work done with

Datura, which showed a intense double band at -17,000 MW on
SDS-PAGE after being purified by ion-exchange chromatography
(9).

This disagrees with more recent data (11), however,

the purification conditions in the study were much less
stringent.
In the peak of antiviral activity from Sephadex G-200,
there are two main areas of activity.

The first -45% of the

peak contains RNase activity and is also antiviral, while
the remainder of the peak has only antiviral activity.

The

entire peak contains the -17,000 MW protein indicating that
this protein is probably responsible for a portion of the
antiviral activity.

The RNase activity is confined to the

fractions containing larger molecules which is supported by
the molecular weight fractionation data.
The elution volumes of the G-200 column fractions were
used to determine the approximate native molecular weight of
the material present.

Knowing that the material was eluted

in a single peak, the molecular weight values of each
fraction were averaged to obtain -87,000 MW as the probable
molecular weight for the active complex.
Protease digestion of the Sephadex G-200 column
fractions shows that the antiviral material is susceptible
to trypsin, indicating that this material is proteinaceous
in nature.

This disagrees with previous data, which
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indicated the antiviral activity was not susceptible to
trypsin (II).
SDS-PAGE data in conjunction with results obtained in
the inhibition assay and RNase activity assay suggest that
there may be at least three compounds in the extract which
are inhibitory.

Of these proteins, one or two are strictly

antiviral (no RNase activity) and the other is inhibitory by
virtue of its RNase activity.

All these data suggest that

the active material is present as a complex of -87,000 MW.
This active complex contains proteins of -17,000 MW and
-12,000 MW, an RNase active protein, and an antiviral
protein of unknown size (probably between 10,000 and 30,000
MW) .

FUTURE STUDIES
Due to the complex nature of this extract further work
needs to be done to identify and characterize the individual
compounds responsible for the observed activities.
Initially, the material
peak

present in

needs to separated into individual

the Sephadex G-200
components.

This

could be accomplished by continuous electrophoretic elution
or HPLC.

This would allow each component to be tested for

both antiviral and RNase activity, which would serve to
identify the component(s) responsible for these actions.
It is possible that the
a complex to be active.

The

material needs to be present as
components

necessary for
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activity could be determined by adding together the isolated
components until the activity is restored.

This should also

Indicate the stoichiometry of the components in the complex.
The RNase active molecule needs to be characterized in
its activity and specificity (34), and an inhibitor of its
activity found.

This would allow the RNase-active portion

to be inactivated to unmask any other activities this
molecule may have.
The possibility that this extract could be a ribosomal
inhibitory protein needs to be investigated.

By using a

cell-free system assay system (such as wheat-germ or rabbit
reticulocyte lysate) and exogenously added mRNA or TMV RNA
as the template, the activity of extract components could be
further characterized.
The virus-stimulating activity observed in some of the
fractions should be further investigated.

Isolating and

characterizing the compound responsible for this activity
may provide insight into virus/inhibitor interaction.
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